From genetics to quality of life : the optimal treatment and management of asthma : proceedings of the XVth World Congress of Asthmology, Montpellier, April 24-27, 1996

Part 1 From epidemiology to genetics and treatment: candidate locus approach to the genetics of asthma and atopy genetic studies of IgE responsiveness and asthma polygenes, asthma and atopy. Part 2 Basic mechanisms of asthma: asthma - relationships between airway inflammatory mediators and lung function basic mechanisms in asthma - endothelial cells implications of bronchial epithelial cells in asthma cell adhesion molecules growth factors in asthma corticosteroid resistant asthma mechanism of aspirin-induced asthma regulation of human IgE synthesis. Part 3 Allergy and air pollution: sensitization of young children air pollutants and allergic sensitization air pollution and asthma - the role of epithelial cells. Part 4 "Infectious " asthma: the role of respiratory infections in asthma viral infections in children with existing asthma treatment of virus-induced asthma in childhood - effect on long-term outcome bacterial sinusitis and its relationship to lower airway hyperreactivity importance of bacterial infection in the aetiopathogenesis of bronchial asthma. Part 5 Optimum asthma management: long term follow-up of asthmatic patients new views on monitoring asthmatic patients from childhood to adulthood - predictive factors anti-inflammatory treatments for asthma - past, present, future the role of education in asthma management. Part 6 New treatments: 5-lipoxygenase inhibition in the treatment of asthma the therapeutic potential of PDE4 inhibitors in asthma transcription factors and asthma a new place for theophylline in asthma IL-5 in pulmonary inflammation IgE modulation - potential for anti-IgE therapy in asthmatic disease asthma and immunotherapy peptide downregulation of the immune response. Part 7 Quality of life: assessment of health-related quality of life in asthma and rhinitis using disease-specific instruments genetic scales of quality of life in asthma and rhinitis can management of asthma reduce costs?